[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
Tag: Healthcare Support Services
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
Cigna-Humana Merger Is Likely to Face Antitrust Challenge
[ad_1] From a financial perspective, a Cigna-Humana megamerger makes a lot of sense. Cigna has a huge pharmacy benefit management business, but has been largely missing out on the highly…
Gene Editing Will Change Medicine—and Maybe Health Investing Too
[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…
Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs
[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…
WSJ News Exclusive | Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs
[ad_1] A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple…
Sam Bankman-Fried to Take the Stand in Fraud Trial
[ad_1] Updated Oct. 25, 2023 11:32 am ET FTX founder Sam Bankman-Fried will testify at his criminal trial, his defense team said Wednesday, in what many legal observers see as…
Sam Bankman-Fried Took Risks at FTX. Will He Bet on His Own Testimony?
[ad_1] FTX founder Sam Bankman-Fried, known for his appetite for risky bets, is mulling perhaps his biggest gamble yet: testifying in his own defense. The onetime crypto star, on trial…
WSJ News Exclusive | Starboard Takes 5%-Plus Stake in Contract-Research Firm Fortrea
[ad_1] The activist investor plans to push for changes that could boost margins among other initiatives aimed at share-price appreciation. [ad_2] Source link